Avet Pharmaceuticals Inc.
Sumi Vigneswaran is a Regulatory Affairs Associate and Technical Writer at Avet Pharmaceuticals Inc. since May 2021, following experience as a Scientist at Primera from October 2020 to May 2021, and at Covance from September 2017 to October 2020. Prior roles include Senior Analyst at Envigo from September 2014 to September 2017, Data Manager at Montefiore Medical Center from February 2013 to March 2014, Bioanalyst at Huntingdon Life Sciences from July 2011 to February 2013, and Research Assistant at Prevention Research Center (PRC) from January 2011 to May 2011, in addition to holding a Research Assistant position at Behavioral Neuroendocrinology Laboratory from May 2010 to May 2011. Sumi Vigneswaran holds a Bachelor of Science in Biology from The Pennsylvania State University, earned in 2011.
Avet Pharmaceuticals Inc.
Avet Pharmaceuticals Inc. is a rapidly growing generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Avet Pharmaceuticals provides high quality generic medicines that help patients and practitioners achieve affordable healthcare solutions. Our global supply chain network is built around centers of manufacturing and scientific excellence to provide you with the highest level of quality, safety, value and service in generics. Our drug portfolio consists of numerous products across a wide range of therapeutic categories, including: cardiovascular, oncology, metabolic disease, anti-infective, infusion and pain management. We are focused on widely utilized, established products as well as niche, high barrier-to-entry products that have limited competition and long life cycles.